Vir Biotechnology Inc (VIR) Stock Forecast & Price Target
Vir Biotechnology Inc · NASDAQ
$8.80+0.11 (+1.27%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Vir Biotechnology Inc, 7 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $14.00 to $30.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $21.14 sits 140% above the current $8.80. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.81 next quarter toward $-2.32 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy7100%
Hold00%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Vir Biotechnology Inc.
As of Jul, 7 of 7 firms rate VIR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
VIR EPS & revenue forecast
EPS · NEXT QUARTER
$-0.81
Range $-1.02 – $-0.65 · 5 analysts · -31% YoY
Next period, 5 analysts expect Vir Biotechnology Inc to earn $-0.81 a share (range $-1.02 – $-0.65), versus $-1.17 a year earlier. Full-year consensus is $-1.37, growing to $-2.32 the year after.
REVENUE · NEXT QUARTER
$320.0K
Range $-30.0K – $1.3M · 5 analysts · +33% YoY
Revenue is expected to reach $320.0K (range $-30.0K – $1.3M), +33.3% year-over-year. Full-year consensus is $249.4M, rising to $112.9M next year.
Top analysts covering Vir Biotechnology Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on VIR.
#1
Joseph Stringer
Needham · Rank #168
Buy
$18.00+104.5% to target
Overall win rate
36%
+ Follow
#2
Patrick R. Trucchio
HC Wainwright & Co. · Rank #203
Buy
$20.00+127.3% to target
Overall win rate
35%
+ Follow
#3
Roanna Ruiz
SVB Leerink
Buy
$21.00+138.6% to target
Coverage
—
+ Follow
#4
MG
Michelle Gilson
Morgan Stanley
Buy
$27.00+206.8% to target
Coverage
—
+ Follow
#5
Cory Kasimov
Evercore ISI Group
Buy
$18.00+104.5% to target
Coverage
—
+ Follow
VIR stock forecast FAQ
What is VIR's average 12-month price target?+
The 7 analysts with a live target average $21.14 for Vir Biotechnology Inc over the next 12 months, ranging from a $30.00 high to a $14.00 low.
Is VIR stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 7 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for VIR?+
The Street-high target is $30.00 (Barclays), and the Street-low is $14.00 (B of A Securities). The average of all 7 active targets is $21.14.
How many Wall Street analysts cover VIR?+
7 analysts have an active rating on Vir Biotechnology Inc, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering VIR?+
Among analysts who currently cover VIR, Joseph Stringer of Needham has the strongest overall Quantellect track record (Rank #168). Their current call is Buy with a $18.00 target.
What is Vir Biotechnology Inc's projected EPS for next quarter?+
The consensus estimate is $-0.81 per share (range $-1.02 – $-0.65) across 5 analysts. Full-year EPS is projected at $-1.37, rising to $-2.32 the following year.
How much revenue is Vir Biotechnology Inc expected to report next quarter?+
Consensus revenue is $320.0K (range $-30.0K – $1.3M). Full-year revenue is projected at $249.4M, growing to $112.9M next year.
Have analysts been upgrading or downgrading VIR lately?+
As of Jul, 7 of 7 firms rate VIR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their VIR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
